A new class of gel-based DO3A-ethylamine-derived targeted contrast agents for MR and optical imaging

Bioconjugate Chemistry

Volumn 17, Issue 3, 2006, Pages 773-780

  Mishra, Anurag ^a   Pfeuffer, Josef ^a,d   Mishra, Ritu ^a   Engelmann, Jörn ^a   Mishra, Anil K ^b   Ugurbil, Kamil ^a,c   Logothetis, Nikos K ^a  

^a MAX PLANCK INSTITUTE FOR BIOLOGICAL CYBERNETICS   (Germany)

^b INSTITUTE OF NUCLEAR MEDICINE AND ALLIED SCIENCES   (India)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^d SIEMENS AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CULTURE; COENZYMES; FLUORESCENCE; FLUORESCENCE MICROSCOPY; GADOLINIUM COMPOUNDS; GLYCOPROTEINS; MAGNETIC RESONANCE IMAGING; OPTICAL IMAGE STORAGE; PROBES;

BI-FUNCTIONAL; CARBOXYMETHYL; ETHYLAMINE; GADOLINIA; GEL-BASED; MR CONTRAST AGENTS; PROBE-BASED; RELAXIVITY; TARGETED CONTRAST AGENTS; TARGETED IMAGING;

LIGANDS;

ETHYL ISOTHIOCYANATE DERIVATIVE; ETHYLAMIDOPROPYLMALEIMIDE; ETHYLTHIOUREAFLUORESCEIN DERIVATIVE; FLUORESCEIN DERIVATIVE; GADOLINIUM; ISOTHIOCYANIC ACID DERIVATIVE; MALEIMIDE DERIVATIVE; UNCLASSIFIED DRUG; [4,7 BIS CARBOXYMETHYL 10 (2 AMINOETHYL) 1,4,7,10 TETRAAZACYCLODEC 1 YL]ACETIC ACID; (4,7 BIS CARBOXYMETHYL 10 (2 AMINOETHYL) 1,4,7,10 TETRAAZA CYCLODODEC 1 YL) ACETIC ACID; (4,7-BIS-CARBOXYMETHYL-10-(2-AMINOETHYL)-1,4,7,10-TETRAAZA-CYCLODODEC-1-YL)-ACETIC ACID; CATION; CONTRAST MEDIUM; ETHYLAMINE; HETEROCYCLIC COMPOUND; LIGAND;

ARTICLE; CONCENTRATION (PARAMETERS); CONCENTRATION RESPONSE; CONJUGATION; CONTRAST ENHANCEMENT; CONTRAST RADIOGRAPHY; DIFFUSION WEIGHTED IMAGING; DOSE TIME EFFECT RELATION; FLUORESCENCE MICROSCOPY; LIGAND BINDING; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTICAL IMAGING; RELAXATION TIME; SYNTHESIS; ANIMAL; CELL STRAIN 3T3; CHEMICAL STRUCTURE; CHEMISTRY; CLASSIFICATION; MOUSE;

ANIMALS; CATIONS; CONTRAST MEDIA; ETHYLAMINES; GADOLINIUM; HETEROCYCLIC COMPOUNDS; LIGANDS; MAGNETIC RESONANCE IMAGING; MICE; MOLECULAR STRUCTURE; NIH 3T3 CELLS;

EID: 33744939195     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc050295b     Document Type: Article

References (58)

1. Lauffer, R. B. (1987) Paramagnetic metal-complexes as water proton relaxation Agents for NMR imaging- theory and design. Chem. Rev. 87, 901-927.
2. 3+ chelates as MRI contrast agents: Structure, dynamics, and applications. Chem. Rev. 99, 2293-2352.
3. Aime, S., Botta, M., Fasano, M., and Terreno, E. (1998) Lanthanide(III) chelates for NMR biomedical applications. Chem. Soc. Rev. 27, 19-29.
4. Merbach, A. E., and Toth, E. (2001) The chemistry of contrast agents in medical magnetic resonance imaging, Wiley, Chichester.
5. 3+ with 1,4,7,10- tetrakis(carboxymethyl)-1,4,7,10-tetraazacyclododecane (DOTA)- Charactrization of three successive complexing Phases: Study of the thermodynamic and structural properties of the complexes by potentiometery, luminescence spectroscopy, and EXAFS. Chem. Eur. J. 10, 5218-5232.
6. Aime, S., Botta, M., Dastru, W., Fasano, M., Panero, M., and Arnelli, A. (1993) Synthesis and characterization of a novel DTPA-like gadolinium(III) complex - A potential reagent for the determination of glycated proteins by water proton NMR relaxation measurements. Inorg. Chem. 32, 2068-2071.
7. Artemov, D. (2003) Magnetic resonance imaging with targeted contrast agents. J. Cell. Biochem. 90, 518-524.
8. Reamer, P., Bader, A., and Weissleder, R. (1998) Preclinical assessment of hepatocyte-targetd MR contrast agents in stable human liver cell cultures. J. Magn. Reson. Imaging 8, 687-689.
9. Leveille-Webster, C., Rogers, J., and Arias, I. (1996) Use of an asialoglycoprotein receptor-targeted magnetic resonance contrast agent to study changes in receptor biology during liver regeneration and endotoxemia in rats. Hepatology 23, 1631-1641.
10. Ni, Y., Marcha, G., Herijgers, P., Flameng, W., Petre, C., Ebert, W., Hilger, C. S., Pfefferer, D., Semmler, W., and Baert, A. L. (1996) Paramagnetic matalloporphyrins: From enhancers of malignant tumors to markers of myocardial infarcts. Acad. Radiol. 3 (Suppl. 2), S395-S397.
11. Frullano, L., Rohovec, J., Aime, S., Maschmeyer, T., Praia, M. L, de Lima, J. J. P., Geraldes, C. F. G. C., and Peters, J. A. (2004) Towards targeted MRI: New MRI contrast agents for sialic acid detection. Chem. Eur. J. 10, 5205-5217.
12. Artemov, D., Mori, N., Ravi, R., and Bhujwalla, Z. M. (2003) Magnetic resonance molecular imaging of the Her-2/neu receptor. Cancer Res. 63, 2723-2727.
13. Boerman, O. C., van Schaijk, F. G., Oyen, W. J. G., and Corstens, F. H. M. (2003) Pretargeted Radioimmunotherapy of cancer: Progress step by step. J. Nucl. Med. 44, 400-410.
14. Sharkey, R. M., Karacay, H., Griffiths, G. L., Behr, T. M., Blumenthal, R. D., Mattes, M. J., Hansen, H. J., and Goldenberg, D. M. (1997) Development of a streptavidin-anti-carcinoembryonic antigen antibody, radiolabeled biotin pre-targeting method for radioimmunotherapy of colorectal cancer. Studies in a human colon cancer xenograft model. Bioconjugate Chem. 8, 595-604.
15. Goodwin, D. A., Meares, C. F., and Osen, M. (1998) Biological properties of biotin-chelate conjugates for pretargeted diagnosis and therapy with the avidin/biotin system. J. Nucl. Med. 39, 1813-1818.
16. Axworthy, D. B., Reno, J. M., Hylarides, M. D., Mallett, R. W., Theodore, L. J., Gustavson, L. M., Su, F.-M., Hobson, L. J., Beaumier, P. L., and Fritzberg, A. R. (2000) Cure for human carcinoma xenografts by a single dose of pretargeted yttrium-90 with negligible toxicity. Proc. Natl. Acad. Sci. 97, 1802-1807.
17. Hainsworth, J., Harrison, P., and Mather, S. J. (2005) Preparation and characterization of a DOTA-lysin-biotin conjugate as an effector molecule for pretargeted radionuclidetherapy. Bioconjugate Chem. 16, 1468-1474.
18. Sakahara, H., and Saga, T. (1999) Avidin-biotin system for delivery of diagnostic agents. Adv. Drug Delivery Rev. 37, 89-101.
19. Goodwin, D. A., and Meares, C. F. (1997) Pretargetting. Cancer Suppl. 80, 2675-2680.
20. Zitvogel, L., and Tursz, T. (2005) In vivo veritas. Nat. Biotechnol. 23, 1372-1374.
21. de Vries, J. M., Lesterhuis, W. J., Barentsz, J. O., Verdijk, P., van Krieken, J. H., Boerman, O. C., Oyen, W. J. G., Bonenkamp, J. J., Boezeman, J. B., Adema, G. J., Bulte, J. W. M., Scheenen, T. W. J., Punt, C. J. A., Heerschap, A., and Figdor, C. G. (2005) Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy. Nat. Biotechnol. 23, 1407-1413.
22. Tacken, P. J., de Vries, J. M., Gijzen, K., Joosten, B., Wu, D., Rother, R. P., Faas, S. J., Punt, C. J. A., Torensma, R., Adema, G. J., and Figdor, C. G. (2005) Effective induction of native and recall T-cell responses by targeting antigen to human dendritic cells via a humanized anti-DC-SIGN antibody. Blood 106, 1278-1285.
23. Dirksen, A., Langereis, S., de Waal, B, F. M., van Genderen, M. H. P., Meijer, E. W., de Lussanet, Q. G., and Hackeng, T. M. (2004) Design and synthesis of bimodal target-specific contrast agents for angiogenesis. Org. Lett. 6, 4857-4860.
24. Modo, M., Cash, D., Mellodew, K., Williams, S. C. R., Fraser, S. E., Meade, T. J., Price, J., and Hodges, H. (2002) Tracking transplanted stem cell migration using bifunctional, contrast agent-enhanced, magnetic resonance imaging. NeuroImage 17, 803-811.
25. Modo, M., Mellodew, K., Cash, D., Fraser, S. E., Meade, T. J., Price, J., Williams, S. C. R. (2004) Mapping transplanted stem cell migration after a stroke: a serial, in vivo magnetic resonance imaging study. NeuroImage 21, 311-317.
26. Crich, S. G., Biancone, L., Cantaluppi, V., Esposito, D. D. G., Russo, S., Camussi, G., and Aime, S. (2004) Improved route for the visualization of stem cells labeled with a Gd-/Eu-chelate as dual (MRI and fluorescence) agent. Magn. Reson. Med. 51, 938-944.
27. 111indium-DOTA chelates: A simple and efficient method. Bioconjugate Chem. 5, 102-104.
28. McCaIl, M. J., Diril, H., and Meares, C. F. (1990) Simplified method for conjugating macrocyclic bifunctional chelating agents to antibodies via 2-iminothiolane. Bioconjugate Chem. 1, 222-226.
29. Rana, T. M., and Meares, C. F. (1990) N-terminal modification of immunoglobulin polypeptide chains tagged with isothiocyanato chelates. Bioconjugate Chem. 1, 357-362.
30. Li, M., and Meares, C. F. (1993) Synthesis, metal chelate stability studies, and enzyme digestion of a peptide-linked DOTA derivative and its corresponding radiolabeled immunoconjugates. Bioconjugate Chem. 4, 275-283.
31. Sieving, P. F., Watson, A. D., and Rocklage, S. M. (1990) Preparation and characterization of paramagnetic polychelates and their protein conjugates. Bioconjugate Chem. 1, 65-71.
32. Herrmann, A., Mihov, G., Vandermeulen, G. W. M., Klok, H.-A., and Mullen, K. (2003) Peptide-functionalized polyphenylene dendrimers. Tetrahedron 59, 3925-3935.
33. Dirksen, A., Langereis, S., de Waal, B. F. M., van Genderen, M. H. P., Meijer, E. W., de Lussanet, Q. G., and Hackeng, T. M. (2004) Design and synthesis of a bimodal target-specific contrast agent for angiogenesis. Org. Lett. 6, 4857-4860.
34. Dirksen, A., Langereis, A., de Waal, B. F. M., van Genderen, M. H. P., Hackeng, T. M., and Meijer, E. W. (2005) A supramolecular approach to multivalent target-specific MRI contrast agents for angiogenesis. Chem. Commun. 2811-2813.
35. Thiers, R. C. (1957) Contamination in trace element analysis and its control. Methods Biochem. Anal. 5, 273-335.
36. Paull, B., and Haddad, P. R. (1999) Chelation ion chromatography of trace metal ions using metallochromic ligands. Trac-Trends Anal. Chem. 18, 107-114.
37. Pfeuffer, J., Merkle, H., Beyerlein, M., Steudel, T., and Logothetis, N. K. (2004) Anatomical and functional MR imaging in the macaque monkey using a vertical large-bore 7 T setup. Magn. Reson. Imaging 22, 1343-1359.
38. Subramanian, R., and Meares, C. F. (1991) Bifunctional chelating agents for radiometal-labeled monoclonal anti-bodies. Cancer Imaging with Radiolabeled Antibodies (Goldenberg, D. M., Ed.) pp 183-199, Kluwer Academic Pubs., Boston.
39. Mishra, A. K. and Chatal, J. F. (2001) Synthesis of macrocyclic bifunctional chelating agents: 1,4,7-tris(carboxymethyl)-10-(2-amino-ethyl)-1,4, 7,10-tetraazacyclododecane and 1,4,8-tris(carboxymethyl)-11-(2-aminoethyl)-1,4, 8,11-tetraazacyclotetradecane. New J. Chem. 25, 336-339.
40. Gries, H., Raduechel, B., Speck, U., and Weinmann, H. J. (1988) Preparation of 1,4,7,10-tetraazacyclododecane-1,4,7-triacetates and their metal salts and complexes as diagnostic aids for X-ray and tomographic diagnoses. (Schering A.-G., Fed. Rep. Ger.). Ger. Offen, 11 pp. CODEN: GWXXBX DE 3625417 Al 19880211 CAN 109: 6552 AN 1988: 406552 CAPLUS.
41. Duimstra, J. A., Femia, F. J.; Meade T. J. (2005) A gadolinium chelate for detection of β-glucuronidase: A self-immolative approach, J. Am. Chem. Soc. 127, 12847-12855.
42. Pope, S. J. A., Kenwright, A. M., Heath, S. L., and Faulkner, S. (2003) Synthesis and luminescence properties of a kinetically stable dinuclear ytterbium complex with differentiated binding sites. Chem. Commun. 13, 1550-1551.
43. Beylin, V. G., and Goel, O. P. (1987) A convenient synthesis of tert-butyl N-(2-bromoethyl)carbamate. Org. Prep. And Proc. Int. 19, 78-80.
44. Weizmann, Y., Patolsky, F., Katz, E., and Willner, I. (2003) Amplified DNA sensing and immunosensing by the rotation of functional magnetic particles. J. Am. Chem. Soc. 125, 3452-3454.
45. Rivera, V. R., Merrill, G. A., White, J. A., and Poli, M. A. (2003) An enzymatic electrochemiluminescence assay for the lethal factor of anthrax. Anal. Biochem. 312, 125-130.
46. Cao, R., Gu, Z., Hsu, L., Patterson, G. D., and Armitage, B. A. (2003) Synthesis and characterization of thermoreversible biopolymer microgels based on hydrogen bonded nucleobase pairing. J. Am. Chem. Soc. 125, 10250-10256.
47. Caswell, K. K., Wilson, J. N., Bunz, U. H. F., and Murphy, C. J. (2003) Preferential end-to-end assembly of gold nanorods by biotin-streptavidin connectors. J. Am. Chem. Soc. 125, 13914-13915.
48. Wilchek, M., and Bayer, E. A. (1990) Methods of Enzymology, Vol. 184, Academic Press, San Diego.
49. Bickel, U., Yoshikawa, T., and Pardridge, W. M. (2001) Delivery of peptides and proteins through the blood-brain barrier. Adv. Drug Delivery Rev. 46, 247-279.
50. Hnatowich, D. J., Virzi, F., and Rusckowski, M. (1987) Investigation of avidin and biotin for imaging applications. J. Nul. Med. 28, 1294-1302.
51. Wilbur, D. S., Hamlin, D. K., Chyan, M.-K., Brian, B. K., and Pathare, P. M. (2001) Biotin reagents for antibody pretargeting. 5. additional studies of biotin conjugate design to provide biotinidase stability. Bioconjugate Chem. 12, 616-623.
52. Rusckowski, M., Fogarasi, M., Fritz, B., and Hnatowich, D. J. (1997) Effect of endogenous biotin on the applications of streptavidin and biotin in mice. Nucl. Med. Biol. 24, 263-268.
53. Sharkay, R. M., Karacay, H., Griffiths, G. L., Behr, T. M., Blumenthal, R. D., Mattes, M. J., Hansen, H. J., and Goldenberg, D. M. (1997) Development of a streptavidin-anti-carcinoembryonic antigen antibody, radiolabeled biotin pretargeting method for radio-immunotherapy of colorectal cancer: studies in a human colon cancer xenograft model. Bioconjugate Chem. 8, 595-604.
54. Gruaz-Guyon, A., Raguin, O., and Barbet, J. (2005) Recent advances in pretargetd radioimmunotherapy. Curr. Med. Chem. 12, 319-338.
55. Foerster, G. J., Santos, E. B., Smith-Jones, P. M., Zanzanico, P., Larson, S. M. (2006) Pretargeted radioimmunotherapy with a single-chain antibody/streptavidin construct and radiolabeled DOTA-biotin: strategies for reduction of the renal dose. J. Nul. Med. 47, 140-149.
56. Wang, Y.-X. J., Hussain, S. M., and Krestin, G. P. (2001) Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging. Eur. Radiol. II, 2319-2331.
57. Weissleder, R., and Mahmood, U. (2001) Molecular imaging. Radiology 219, 316-333.
58. Hüber, M. M., Staubli A. B., Kustedjo, K., Gray, M. H. B., Shih, J., Fraser, S. E., Jacobs, R. E., and Meade, T. J. (1998) Fluorescently detectable magnetic resonance imaging agents. Bioconjugate Chem. 9, 242-249.